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Inflammatory Myofibroblastic Tumor
Report of a Rare Case in Kidney
Diana Taheri,1,2 Neda Soleimani,1 Mehdi Fesharakizadeh,3 
Shahaboddin Dolatkhah,4 Mahmood Kabiri,5 Abolfazl Gholipour6
Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm 
mostly seen in the lungs, but also in extrapulmonary sites. The 
most common genitourinary site of IMT is the bladder, but it may 
rarely be seen in the kidneys. We report a case of a 15-year-old 
girl presented with flank pain and hematuria, in which computed 
tomography scan revealed a mass in the left kidney. The patient 
underwent left nephrectomy for a diagnosis of Wilms tumor. 
Further assessment of the tissue demonstrated a pathologic 
diagnosis of IMT. Despite improvements in imaging technology, 
the preoperative diagnosis of IMT remains difficult and surgery is 
the only way for the diagnosis and treatment. Considering the role 
of the pathologic examination in making the definite diagnosis of 
IMT, we should be aware of this entity and it must be considered 
in the differential diagnoses.
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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is a 
rare disease of the kidney which may be seen at 
any ages and any anatomic location.1 Although 
recent studies suggested the neoplastic process 
of the disease, its origin was doubtful to be a 
neoplasm or a postinflammatory process.2 Although 
the most commonest site of IMT is the lung, as 
first described in 1937, there are some reports of 
IMT in the extrapulmonary sites.3,4 Inflammatory 
myofibroblastic tumor could also be seen in the 
genitourinary system, mostly in the bladder,5 and 
its occurrence in the kidney is rare. Therefore, it 
may misdiagnosed as a malignant tumor during 
clinical and pathological evaluations of a renal 
mass.6 First case of the IMT of kidney was published 
in 1972.3 Herein, we report a case of a 15-year-old 
girl with IMT who was misdiagnosed with Wilms 
tumor based on imaging findings, but further 
pathologic assessment showed the original process 
of the disease.
CASE REPORT
A 15-year-old girl was referred to Alzahra 
Hospital (affiliated to Isfahan University of Medical 
Sciences, Isfahan, Iran) with a left renal mass. This 
was discovered incidentally during her evaluation 
for the complaints of weight loss for 2 months, 
hematuria, and flank pain. Past medical, social, and 
family history of the patient was unremarkable. 
Basic laboratory examinations revealed normal 
hematological and biochemical parameters of 
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complete blood count and serum biochemistry. 
Urinalysis results were normal.
A contrast-enhanced computed tomography scan 
showed a solid mass with round borders in the upper 
pole of the left kidney. It was slightly enhanced 
with contrast, suggesting a malignant neoplasm. 
The contralateral kidney was normal. Considering 
the clinical and radiologic findings, malignancy, 
particularly Wilms tumor, was suspected. A left 
radical nephrectomy plus adrenalectomy was 
performed. Grossly, a yellowish well-defined mass 
measuring 13.5 cm in its greatest dimension was 
found in the upper pole of the left kidney. Renal 
capsule was intact.
Histologic examination of the specimen showed 
proliferation of spindle cells with elongated 
cytoplasmic processes in a loose edematous and 
myxoid background. Nucleoli revealed occasional 
atypia and some contained prominent nucleoli. 
Diffuse lymphoplasmacytic inflammation with 
occasional eosinophis and neutrophils infiltration 
was found.  Immunohistochemical  staining 
demonstrated the spindle cells diffusely positive 
for vimentin, and focally positive for both actin 
and anaplastic lymphoma kinase (ALK; Figures 1 
and 2). Staining for epithelial membrane antigen, 
cytokeratin 7,  CD34, Bcl2,  and desmin was 
negative. A final diagnosis of IMT was made. The 
remaining renal parenchyma and adrenal gland 
were unremarkable and surgical margins were 
free of tumor. 
The patients was doing well during the follow-
up period with no evidence of disease recurrence 
for 1 year after the surgery.
DISCUSSION
Inflammatory myofibroblast ic  tumor,  or 
inflammatory pseudotumor  (as named before), 
is a proliferative lesion of spindle cells which 
mainly affects the lungs, but also may be seen 
in other extrapulmonary sites.7,8 Renal IMT is 
a rare pathologic diagnosis because of its rare 
occurrence. Also, the histological changes make 
the diagnosis difficult. It is composed of spindle 
cells with variable inflammatory component.2 There 
are 3 histologic patterns for IMT: a myxoid and 
vascular pattern with inflammatory infiltrate (same 
as our case), compact spindle cell proliferation, 
and hypocellular fibrous pattern.4 Preoperative 
diagnosis of IMT is only confirmed by nephrectomy 
and pathologic assessment.9 Differential diagnoses 
of renal IMT are renal cell carcinoma, sarcomatoid 
urothelial carcinoma, leiomyosarcoma, and 
rhabdomyosarcoma.3 Follow-up of patients did 
not show any recurrences or metastases of IMT. 
Local recurrences and malignant transformation 
have been reported in a small subset of patients.10 
Previous studies suggested Epstein-Barr virus 
and human herpesvirus 8 as a major cause of 
IMT, Yamamoto et al. evaluated 21 patients with 
IMT, Epstein-Barr virus and human herpesvirus 
8 were both negative among them.11 Anaplastic 
lymphoma kinase (ALK), which is used in diagnosis 
of anaplastic large cell lymphoma, is expressed in 
IMT cells caused by chromosomal translocation of 
the ALK gene (chromosome 2p23) with a partner 
gene (nucleophosmin or others), which is useful 
in confirming the diagnosis.8,12,13 
Figure 1. Positive cytoplasmic immunostaining for anaplastic 
lymphoma kinase (ALK1).
Figure 2. Spindle cell proliferation in an edematous stroma 
with scattered acute and chronic inflammatory cell infiltration 
(hematoxylin-eosin, × 100).
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Despite recent improvements in imaging 
technology, preoperative diagnosis of IMT remains 
a dilemma, and final diagnosis is based on 
histopathologic evaluation of the involved tissue. 
In the present case, a left radical nephrectomy was 
carried out as the disease was presumed to be a 
Wilms tumor. However, histopathological diagnosis 
suggested IMT and expression of vimentin, smooth 
muscle actin, and ALK confirmed IMT as the 
final diagnosis. Careful histologic examination 
and immunohistochemical staining will generally 
determine the appropriate diagnosis. As nearly 
all the reported cases of IMT had long disease-
free survival, we suggest IMT be considered as 
a differential diagnosis for renal masses. Further 
studies are required to find an accurate way for 
preoperative diagnosis of IMT.
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